I-PRO is at the forefront of research, technological innovation, strategic marketing and training.
A services company with an expertise in writing and management of national and international projects.
A services company with an expertise in writing and management of national and international projects.
NEWS
March 2022 - In the tragic conditions imposed by war in Europe, scientists unite to keep scientific collaboration alive and to support peace and its reasons together, promote dialogue, condemn war, open the doors to all those who are forced to flee from war or persecution. May science give peace a chance.
Year 2015Kurdistan Region, 22-26 November 2015
In the framework of the Pilot project funded by the Kurdistan Regional Government and by the Italian Cooperation, coordinated by the University of Tor Vergata, the Italian Consul, the Kurdish Minister of Health, and all the directorates, gave their support to the first training session about the District Health Information System and ICD 10, implemented with the participation of IPRO (Diaries of the training days at linkedinIPRO / File) read more >> Rome, 15-18 September 2015
I-PRO supported the management and realized the website of the ESBP2015 - 8th European Symposium on Biopolymers - hosted by the Department of Chemistry, University of Rome, LA SAPIENZA, and opened in the Museum of Classical Art, of the university museums complex. Visit the website www.esbp2015.org ARCA MENTOR SCHOOL || siena, 28-29 maY 2015
|
I-PRO received the European Commission's Seal of Excellence for "PINGURO".
I-PRO is certified UNI EN ISO 9001-2015 for the design and distribution of services in Continuous Medical Education (CME) and clinical research for pharmaceutical companies (CRO).
I-PRO is registered in the list of the National Research MIUR (Ministry of University Education and Research).
follow us on
watch our video on
|
The computerworld honors program LAUREATE for EURESIST PROJECT
EuResist developed a drug interaction modeling tool that lets users predict the success rate and impact on virus evolution of various drug combinations via an online portal.